Qiang Zhang

机构：University of Shanghai for Science and Technology, China Pharmaceutical University, Peking University, University of Macau, Northwest Normal University · ORCID：0000-0002-8862-3098

发表论文 478 篇 · 总被引 23701 次 · h-index 86

代表论文

• An Endoplasmic Reticulum Stress‐Specific Nanoinducer Selectively Evokes Type‐II Immunogenic Cell Death for Pyroptotic Cancer Immunotherapy (2025 · Advanced Materials · 被引 44)
• Magnetic Field Driven Ceria Nanosystems for Mitochondria Targeted Therapy of Ischemic Stroke (2025 · Advanced Functional Materials · 被引 31)
• Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial (2025 · Signal Transduction and Targeted Therapy · 被引 20)
• Metallic nanomedicine in cancer immunotherapy (2025 · Acta Pharmaceutica Sinica B · 被引 17)
• Inhalable neutrophil-mimicking nanoparticles for chronic obstructive pulmonary disease treatment (2025 · Journal of Controlled Release · 被引 15)
• Prediction of herbal compatibility for colorectal adenoma treatment based on graph neural networks (2025 · Chinese Medicine · 被引 15)